PURPOSE
Despite significant advances in melanoma treatment, many survivors continue to experience long-term effects of disease and therapy. Various survivorship care programs have been developed in recent years, but these differ in terms of their scope, content, and delivery. The aim of this scoping review was to summa...
Madlen Hörold, Sasha Schutkowski, K. Drewitz et al.· Journal of cancer survivorsh...· 0 citations
Robust long‐term survival data have transformed the prognosis of metastatic melanoma. For combination therapy with immune checkpoint inhibitors (ICIs), 10‐year melanoma‐specific survival rates now exceed 50 %, and durable disease control is achievable in a substantial proportion of patients, including those with brain...
Markus Reitmajer, S. Dugas-Breit, C. Blomen et al.· Journal der Deutschen Dermat...· 0 citations
